tert-butyl 4-[(2-methoxy-2-oxoethyl)amino]piperidine-1-carboxylate hydrochloride, 1g

Methyl 2-oxocyclohexanecarboxylate, 95.0%, 100g

6-Methoxy-3h-imidazo[4,5-c]pyridine, 98%, 250mg

N-Hydroxy-4-o-tolyl-pyridine-2-carboxamidine, 95.0%, 1g

(3,5-Bis((3,5-dimethoxybenzyl)oxy)phenyl)methanol, 95+%, 1g

Morpholin, min. 99 %, zur Synthese, 2.5 l, Glasverpackung

2-(2-Methoxyethoxy)-5-(trifluoromethyl)aniline, 98%, 250mg

4-Fluorostyrene (stabilised with TBC), 95.0%, 1g

2-Chloro-4-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 96%, 1g

3-Fluoro-N,N-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95+%, 1g

5-(3-Fluorophenyl)-2H-tetrazole, 98.0%, 250mg

7-chloro-1-(4-fluoro-3-methylphenyl)-1-oxoheptane, 97.0%, 1g

(2-Methyl-5-(pyrrolidin-1-ylsulfonyl)phenyl)boronic acid, 95.0%, 5g